TTOO - T2 Biosystems, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,847
10,500
4,666
4,080
2,813
Cost of Revenue
17,881
15,404
12,028
6,872
1,740
Gross Profit
-10,034
-4,904
-7,362
-2,792
1,073
Operating Expenses
Research Development
13,971
14,489
23,733
24,009
25,362
Selling General and Administrative
26,107
25,697
22,757
24,077
19,094
Total Operating Expenses
40,078
40,186
46,490
48,086
44,456
Operating Income or Loss
-50,112
-45,090
-53,852
-50,878
-43,383
Interest Expense
7,390
6,682
8,907
-
-
Total Other Income/Expenses Net
792
619
331
172
60
Income Before Tax
-56,710
-51,153
-62,428
-54,804
-45,290
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-56,710
-51,153
-62,428
-54,804
-45,290
Net Income
-56,710
-51,153
-62,428
-54,804
-45,290
Net Income available to common shareholders
-56,710
-51,153
-62,428
-54,804
-45,290
Reported EPS
Basic
-
-1.26
-1.94
-2.11
-2.21
Diluted
-
-1.26
-1.94
-2.11
-2.21
Weighted average shares outstanding
Basic
-
40,559
32,132
26,016
20,502
Diluted
-
40,559
32,132
26,016
20,502
EBITDA
-
-42,022
-50,581
-48,598
-41,918